The role of tumor necrosis factor-α in the pathogenesis of vitiligo

Carlos R. Camara-Lemarroy, Julio C. Salas-Alanis

Research output: Contribution to journalLiterature review

10 Citations (Scopus)

Abstract

Vitiligo is an acquired immune disorder of the skin characterized by the presence of white depigmented macules. Its immunopathogenesis is not completely understood, but inflammatory alterations in the skin microenvironment, and particularly increased expression of the cytokine tumor necrosis factor-α (TNFα), are thought to be essential regulators of melanocyte dysfunction and death. In this article we review the evidence that implicates TNFα in the pathogenesis of vitiligo, including studies on serum and tissue levels of TNFα, TNFα gene polymorphisms, in vitro studies, and therapeutic trials using TNFα inhibitors. TNFα emerges as a complex mediator with apparently conflicting roles in vitiligo. © 2013 Springer International Publishing Switzerland.
Original languageEnglish
Pages (from-to)343-350
Number of pages8
JournalAmerican Journal of Clinical Dermatology
DOIs
Publication statusPublished - 1 Oct 2013

Fingerprint

Vitiligo
Tumor Necrosis Factor-alpha
Mediator Complex
Skin
Melanocytes
Immune System Diseases
Switzerland
Cytokines
Serum
Genes

Cite this

Camara-Lemarroy, Carlos R. ; Salas-Alanis, Julio C. / The role of tumor necrosis factor-α in the pathogenesis of vitiligo. In: American Journal of Clinical Dermatology. 2013 ; pp. 343-350.
@article{c49a369c1d0e4f6ebf02b0aa225dc3ef,
title = "The role of tumor necrosis factor-α in the pathogenesis of vitiligo",
abstract = "Vitiligo is an acquired immune disorder of the skin characterized by the presence of white depigmented macules. Its immunopathogenesis is not completely understood, but inflammatory alterations in the skin microenvironment, and particularly increased expression of the cytokine tumor necrosis factor-α (TNFα), are thought to be essential regulators of melanocyte dysfunction and death. In this article we review the evidence that implicates TNFα in the pathogenesis of vitiligo, including studies on serum and tissue levels of TNFα, TNFα gene polymorphisms, in vitro studies, and therapeutic trials using TNFα inhibitors. TNFα emerges as a complex mediator with apparently conflicting roles in vitiligo. {\circledC} 2013 Springer International Publishing Switzerland.",
author = "Camara-Lemarroy, {Carlos R.} and Salas-Alanis, {Julio C.}",
year = "2013",
month = "10",
day = "1",
doi = "10.1007/s40257-013-0039-3",
language = "English",
pages = "343--350",
journal = "American Journal of Clinical Dermatology",
issn = "1175-0561",
publisher = "Adis International Ltd",

}

The role of tumor necrosis factor-α in the pathogenesis of vitiligo. / Camara-Lemarroy, Carlos R.; Salas-Alanis, Julio C.

In: American Journal of Clinical Dermatology, 01.10.2013, p. 343-350.

Research output: Contribution to journalLiterature review

TY - JOUR

T1 - The role of tumor necrosis factor-α in the pathogenesis of vitiligo

AU - Camara-Lemarroy, Carlos R.

AU - Salas-Alanis, Julio C.

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Vitiligo is an acquired immune disorder of the skin characterized by the presence of white depigmented macules. Its immunopathogenesis is not completely understood, but inflammatory alterations in the skin microenvironment, and particularly increased expression of the cytokine tumor necrosis factor-α (TNFα), are thought to be essential regulators of melanocyte dysfunction and death. In this article we review the evidence that implicates TNFα in the pathogenesis of vitiligo, including studies on serum and tissue levels of TNFα, TNFα gene polymorphisms, in vitro studies, and therapeutic trials using TNFα inhibitors. TNFα emerges as a complex mediator with apparently conflicting roles in vitiligo. © 2013 Springer International Publishing Switzerland.

AB - Vitiligo is an acquired immune disorder of the skin characterized by the presence of white depigmented macules. Its immunopathogenesis is not completely understood, but inflammatory alterations in the skin microenvironment, and particularly increased expression of the cytokine tumor necrosis factor-α (TNFα), are thought to be essential regulators of melanocyte dysfunction and death. In this article we review the evidence that implicates TNFα in the pathogenesis of vitiligo, including studies on serum and tissue levels of TNFα, TNFα gene polymorphisms, in vitro studies, and therapeutic trials using TNFα inhibitors. TNFα emerges as a complex mediator with apparently conflicting roles in vitiligo. © 2013 Springer International Publishing Switzerland.

U2 - 10.1007/s40257-013-0039-3

DO - 10.1007/s40257-013-0039-3

M3 - Literature review

SP - 343

EP - 350

JO - American Journal of Clinical Dermatology

JF - American Journal of Clinical Dermatology

SN - 1175-0561

ER -